je.st
news
's Top Downgrades
2015-08-31 18:26:59| Paper - Topix.net
Chardan Capital downgraded Regeneron Pharmaceuticals Inc from Buy to Neutral. The target price for Regeneron Pharmaceuticals is set to $565.
Tags: top
downgrades
Category:Materials
Latest from this category |
All news |
||||||||||||||||||||
|
|